EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation

EPA:ERF • FR0014000MR3

Current stock price

59.76 EUR
-1.78 (-2.89%)
Last:

This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ERF.PA Profitability Analysis

1.1 Basic Checks

  • ERF had positive earnings in the past year.
  • ERF had a positive operating cash flow in the past year.
  • ERF had positive earnings in each of the past 5 years.
  • In the past 5 years ERF always reported a positive cash flow from operatings.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ERF has a better Return On Assets (3.73%) than 62.50% of its industry peers.
  • ERF has a better Return On Equity (9.02%) than 68.75% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.74%, ERF is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • ERF had an Average Return On Invested Capital over the past 3 years of 6.44%. This is in line with the industry average of 7.18%.
  • The 3 year average ROIC (6.44%) for ERF is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 6.74%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ERF has a Profit Margin of 5.62%. This is comparable to the rest of the industry: ERF outperforms 56.25% of its industry peers.
  • ERF's Profit Margin has declined in the last couple of years.
  • ERF has a Operating Margin (10.87%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ERF has declined.
  • With a Gross Margin value of 21.39%, ERF is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ERF has declined.
Industry RankSector Rank
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ERF.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERF is destroying value.
  • The number of shares outstanding for ERF has been reduced compared to 1 year ago.
  • The number of shares outstanding for ERF has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ERF has a worse debt to assets ratio.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • ERF has an Altman-Z score of 2.46. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.46, ERF is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • The Debt to FCF ratio of ERF is 5.14, which is a neutral value as it means it would take ERF, 5.14 years of fcf income to pay off all of its debts.
  • ERF has a better Debt to FCF ratio (5.14) than 81.25% of its industry peers.
  • ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
  • ERF has a Debt to Equity ratio (0.82) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.46
ROIC/WACC0.81
WACC8.28%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • ERF has a Current Ratio of 1.09. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • ERF has a Current ratio (1.09) which is comparable to the rest of the industry.
  • ERF has a Quick Ratio of 1.03. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, ERF is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ERF.PA Growth Analysis

3.1 Past

  • ERF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • The Earnings Per Share has been decreasing by -3.09% on average over the past years.
  • ERF shows a small growth in Revenue. In the last year, the Revenue has grown by 4.96%.
  • ERF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • Based on estimates for the next years, ERF will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.62% on average per year.
  • Based on estimates for the next years, ERF will show a quite strong growth in Revenue. The Revenue will grow by 8.50% on average per year.
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y15.62%
Revenue Next Year4.58%
Revenue Next 2Y5.55%
Revenue Next 3Y6.04%
Revenue Next 5Y8.5%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. ERF.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.06, ERF is valued correctly.
  • Based on the Price/Earnings ratio, ERF is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of ERF to the average of the S&P500 Index (27.15), we can say ERF is valued slightly cheaper.
  • ERF is valuated correctly with a Price/Forward Earnings ratio of 15.60.
  • Based on the Price/Forward Earnings ratio, ERF is valued a bit cheaper than 75.00% of the companies in the same industry.
  • ERF is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.06
Fwd PE 15.6
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERF is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • ERF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ERF is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.2
EV/EBITDA 9.54
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ERF's earnings are expected to grow with 13.59% in the coming years.
PEG (NY)2.52
PEG (5Y)N/A
EPS Next 2Y11.18%
EPS Next 3Y13.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ERF.PA Dividend Analysis

5.1 Amount

  • ERF has a Yearly Dividend Yield of 1.16%.
  • ERF's Dividend Yield is rather good when compared to the industry average which is at 0.57. ERF pays more dividend than 87.50% of the companies in the same industry.
  • ERF's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

  • The dividend of ERF is nicely growing with an annual growth rate of 16.09%!
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ERF pays out 26.80% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ERF is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP26.8%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ERF.PA Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

EPA:ERF (4/28/2026, 5:36:15 PM)

59.76

-1.78 (-2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-22
Earnings (Next)07-21
Inst Owners35.09%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.52B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.19 (20.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.3%
PT rev (3m)5.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.79%
EPS NY rev (3m)-5.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE 16.06
Fwd PE 15.6
P/S 1.44
P/FCF 12.2
P/OCF 7.52
P/B 2.32
P/tB N/A
EV/EBITDA 9.54
EPS(TTM)3.72
EY6.22%
EPS(NY)3.83
Fwd EY6.41%
FCF(TTM)4.9
FCFY8.2%
OCF(TTM)7.95
OCFY13.3%
SpS41.46
BVpS25.81
TBVpS-4.57
PEG (NY)2.52
PEG (5Y)N/A
Graham Number46.4828 (-22.22%)
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 9.27%
ROIC 6.74%
ROICexc 7.43%
ROICexgc 23.86%
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
FCFM 11.82%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.44
Cap/Depr 74.23%
Cap/Sales 7.35%
Interest Coverage 6.87
Cash Conversion 92.26%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.46
F-Score7
WACC8.28%
ROIC/WACC0.81
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y15.62%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.58%
Revenue Next 2Y5.55%
Revenue Next 3Y6.04%
Revenue Next 5Y8.5%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.58%
EBIT Next 3Y28.7%
EBIT Next 5Y21.02%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ERF.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


What is the profitability of ERF stock?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for ERF stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ERF.PA) is 16.06 and the Price/Book (PB) ratio is 2.32.


What is the financial health of EUROFINS SCIENTIFIC (ERF.PA) stock?

The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10.